R-CEOP as first-line treatment for anthracycline-ineligible patients with diffuse large B-cell lymphoma

Diana Al-Sarayfi, Frederik O. Meeuwes, Müjde Durmaz, Djamila E. Issa, Rolf E. Brouwer, Aart Beeker, Anna van Rhenen, Pim G.N.J. Mutsaers, Lara H. Böhmer, Marjolein W.M. van der Poel, Liane Te Boome, Tom van Meerten, Martine E.D. Chamuleau, Josée M. Zijlstra, Mirian Brink, Marcel Nijland*

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

2 Citations (Scopus)
22 Downloads (Pure)
Original languageEnglish
Article number125
Pages (from-to)125
Number of pages1
JournalBlood Cancer Journal
Volume12
Issue number9
DOIs
Publication statusPublished - 2 Sept 2022

Cite this